Phase 1 Trials Phase 1 trials for Retatrutide primarily focused on: Establishing the safety and optimal dosage range of the drug Involving small groups of healthy volunteers who received varying doses of Retatrutide to identify the most effective and safe dosage levels Monitoring for any adverse effects, which were generally mild and manageable This initial phase was pivotal in laying the groundwork for subsequent efficacy trials, including a clinical trial
"When I was bigger, if they had Ozempic, I probably would have tried it cause I tried any other thing," she said, referencing the diabetes drug that has gained popularity as a weight loss tool
Microdosing involves consuming a dose below the standard therapeutic dose to achieve certain benefits and minimize the risk of side effects
Liraglutide and exendin-4 are initially antidiabetic drugs but can affect tumorigenesis, suggesting GLP-1R agonists as a potential treatment for different cancers as found in vivo (Table 2)
Anti-obesity medication (AOM) prescribing increased slightly in December 2024 compared to September 2024 (+6.98%)
Small-molecule composition of matter (COM) patents feature a classical generic Markush drawn around examples with the lead clinical candidate(s) at the core